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A derivative and possible physiological metabolite of disulfiram, diethyldithiocarbamic acid methanethiol 
mixed disulfide, is shown here for the first time to inactivate the mitochondrial low-K,,, isozyme of human 
aldehyde dehydrogenase (EC 1.2.1.3). By comparing inactivating effects of diethyldithiocarbamic acid 
mixed disulfides with thiols of increasing chain length evidence is provided that steric hindrance is the reason 
for lack of inhibition of the mitochondrial enzyme by disulliram in vitro. Since methanethiol is a normal 
metabolite [( 1983) Annu. Rev. Biochem. 52, 187-2221 the results also suggest a mechanism by which alde- 
hyde dehydrogenase is inhibited by disulliram and diethyldithiocarbamic acid in vivo. 
Mitochondrial aldehyde dehydrogenase DisulJiram 
1. INTRODUCTION 
Disulfiram (tetraethylthiuram disulfide, Anta- 
buse, see fig.1) is an aversive agent used clinically 
in the treatment of alcoholism. Disulfiram and its 
primary metabolite diethyldithiocarbamic acid ap- 
pear to function in vivo by irreversible [l] inhibi- 
tion of both cytoplasmic and mitochondrial low- 
K,,, aldehyde dehydrogenase [2,3]. However, when 
the low-K,,, isozymes were purified from several 
mammalian species [4-61 it was found that diethyl- 
dithiocarbamic acid was non-inhibitory and that 
disulfiram inhibited only the cytoplasmic isozyme. 
Recently the mechanism by which disulfiram in- 
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Fig.1. Chemical formulae of disulfiram and diethyldi- 
thiocarbamic acid methanethiol mixed disulfide. 
Diethyldithiocarbamic acid methanethiol mixed disulfide 
hibits the human cytoplasmic isozyme has been 
reported in detail 171. 
Studies indicate that acetaldehyde oxidation in 
vivo is catalyzed by the mitochondrial isozyme [8]. 
Due to the ineffectiveness of disulfiram and 
diethyldithiocarbamic acid with the mitochondrial 
isozyme in vitro it has been suggested that a meta- 
bolite may inhibit in vivo. Known metabolic pro- 
ducts (carbon disulfide, diethylamine and diethyl- 
dithiocarbamic acid methyl ester) [9-l l] have been 
tested but found to be non-inhibitory and ex- 
periments using mixed disulfides between diethyl- 
dithiocarbamic acid and physiological sulfhydryl 
compounds (glutathione, cysteine) have been in- 
conclusive [ 121. (We synthesized mixed disulfides 
of diethyldithiocarbamic acid with the following 
compounds: glutathione, cysteine, coenzyme A, 
ergothionine, and lipoamide and tested them as in- 
hibitors of the mitochondrial aldehyde dehydro- 
genase. Only the lipoamide derivative was slightly 
inhibitory and only when used in a large excess in 
an extended incubation. Diethyldithiocarbamic 
acid methyl ester was also tested and found to be 
ineffective.) Here we examine inhibitory properties 
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of a series of diethyldithiocarbamic acid mixed 
disulfides and suggest an explanation as to why 
disulfiram and diethyldithiocarbamic acid are po- 
tent inhibitors of the mitochondrial isozyme in 
vivo but not in vitro. 
of disulfiram in 95% ethanol and stirring the mix- 
ture at room temperature for several days. Meth- 
anethiol was first formed by addition of sodium 
borohydride (l/2 equimolar amount) to dimethyl 
disulfide prior to addition of disulfiram. Analysis 
and purification of the mixed disulfides were ner- 
2. MATERIALS AND METHODS 
Chemicals used include: glutathione, ergothio- 
nine, 2-mercaptoethanol, coenzyme A, lipoamide, 
EDTA, cysteine, sodium borohydride, silica gel 
(Sigma); dimethyl disulfide and ethanethiol-oc- 
tanethiol (Aldrich); thin-layer chromatographic 
plates (Macherey-Nagel); disulfiram (Ayerst) and 
nicotinamide adenine dinucleotide (NAD+) 
(Boehringer-Mannheim). Synthesis of the various 
diethyldithiocarbamic acid mixed disulfides (table 
1) was accomplished by reacting the appropriate 
sulfhydryl compound with an equimolar amount 
formed using chromatography on silica gel in a 
hexane :methylene chloride (6 : 4) system. Overall 
yields were around 20%. Identification of com- 
pounds was performed using ‘H and 13C NMR (see 
table 1). 
The mitochondrial low-K,,, E2 isozyme was 
purified to homogeneity from human liver [13]; 
prior to use the enzyme was dialyzed against 8 
changes of Nz-saturated 30 mM phosphate buffer 
(pH 6.0) containing 1 mM EDTA at 4°C. Meas- 
urement of activity was done spectrophotometri- 
tally at 340 nm and 25°C in 30 mM phosphate (pH 
7.0) containing 500,uM NAD+, 1 mM propional- 
Table 1 
Spectral properties for various diethyldithiocarbamic acid mixed disulfides and their second-order ate constants for 
inactivation of the mitochondrial (E2) isozyme 
Compound Proton NMR (Ccl& S(ppm) Carbon 13 (CDCls), G(ppm) Second-order 
(fully decoupled) rate constants 
(CIM .min)-’ 
Disulfiram 
DDC-methanethiol 
DDC-ethanethiol 
DDC-n-propanethiol 
DDC-n-butanethiol 
DDC-n-pentanethiol 
DDC-n-hexanethiol 
DDC-n-heptanethiol 
DDC-n-octanethiol 
1.42 (t,12H), 4.01 (q,8H) 
1.30(t,6H), 2.46(s,3H), 
3.6-4.3(s,4H) 
1.32(t,9H), 286(q,2H), 
3.6-4.2(s,4H) 
0.82-2,0(m,llH), 2.83(t,2H), 
3.6-4.3(s,4H) 
0.70-2.0(m,13H), 2.83(t,2H), 
3.6-4.2(s,4H) 
0.70-1.95(m,15H), 2.84(t,2H), 
3.6-4.3(s,4H) 
0.651.98(m,17H), 2.84(t,2H), 
3.6-4.3(s,4H) 
0.651.98(m,19H), 2.85(t,2H), 
3.6-4.3(s,4H) 
0.65-1.95(m,21H), 2.85@,2H), 
3.6-4.3(s,4H) 
11.24(2(3), 13.71(2C), 47.37(2(3), 
51.72(2(3), 192.30(2<=) 
10.27, 11.94, 21.57, 45.72, 50.04, 
193.07 
10.98, 12.60, 13.19, 31.82, 46.51, 
51.01, 195.22 
10.80, 12.48(2(3), 21.15, 39.77, 
46.31, 50.81, 194.92 
10.76, 12.40, 12.93, 20.93, 29.84, 37.52, 
46.26, 50.71, 194.87 
10.82, 12.40, 13.24, 21.54, 27.51, 29.96, 
37.84, 46.30, 50.78, 195.00 
10.89, 12.45, 13.41, 21.86, 27.59, 27.86, 
30.76, 37.97, 46.35, 50.87, 195.12 
10.94, 12.53, 13.47, 21.97, 27.83(2(3), 
28.24, 31.09, 38.00, 46.46, 50.93, 195.18 
10.86, 12.50, 13.47, 22.00, 27.89(2(3), 
28.49(2(7), 31.15, 37.94, 46.37, 50.88, 
195.10 
DDC- 1.30(t,6H), 2.93(t,2H), 10.50, 12.20, 41.54, 46.43, 51.15, 57.73, 
2-mercaptoethanol 3.4-4.3(m,7H) 195.17 
0.001 
20.6 
1.07 
0.57 
0.36 
0.18 
0.005 
0.001 
0.001 
0.78 
DDC, diethyldithiocarbamic acid. Infrared spectra of DDC-methanethiol revealed the following peaks (I’,,,‘,,, cm-‘); 
1483 (N-C= S), 1360 and 1383 (C=S) and 1205, 1155 and 1090 (tertiary amine) 
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dehyde, and 1 mM EDTA. Protein concentrations 
were determined by absorption at 280 nm [ 141. En- 
zyme inactivation was determined by adding en- 
zyme to a cuvette containing 30 mM phosphate 
(pH 7), 1 mM EDTA, 150/1M acetaldehyde, 500 
PM NAD+ and the appropriate mixed disulfide in- 
hibitor in 3 ml total volume. The resulting steady- 
state rates were then determined spectrophoto- 
metrically and compared with control containing 
no inhibitor. Second-order rate constants were 
determined using the above system with inhibitors 
at a stoichiometry of two equivalents (0.46 PM) 
per enzyme tetramer (0.23pM), M, 216000 [14]. 
Determination of rate constants was performed by 
measuring the decrease in rate with time and apply- 
ing the following equation [15]: 
l/E- ~/EC, = bKzt 
where E represents the active enzyme concentra- 
tion at time t, EO is the active enzyme concentration 
at t = 0, b is the ratio of inhibitor to enzyme and 
equals 2, KZ is the second-order ate constant. 
3. RESULTS AND DISCUSSION 
During this investigation we observed that the 
human mitochondrial E2 isozyme could be in- 
hibited by disulfiram in the presence of trace 
amounts of 2-mercaptoethanol. (2-Mercaptoetha- 
no1 is a sulfhydryl reducing agent which is routine- 
ly incorporated into isolation and storage buffers 
to protect aldehyde dehydrogenase against oxida- 
tion and inactivation, but is generally removed 
from enzyme samples before experimental use. 
Only following exhaustive dialysis of the mito- 
chondrial isozyme could a consistent and accurate 
determination of its activity in the presence of 
disulfiram be obtained.) The diethyldithiocar- 
bamic acid 2-mercaptoethanol mixed disulfide was 
therefore synthesized (table 1) and tested as an in- 
hibitor of mitochondrial isozyme activity. Addi- 
tion of an excess of the inhibitor (16 molar equiva- 
lents per enzyme tetramer) directly to the reaction 
already in progress resulted in rapid and total in- 
hibition which was not reversed by dialysis. Subse- 
quent addition of excess 2-mercaptoethanol (10 
mM) restored enzyme activity to its original value. 
Preincubation of the enzyme with stoichiometric 
amounts of inhibitor (4 molar equivalents per 
tetramer) prior to assay resulted in almost total 
loss of initial activity (O-12% of original). These 
observations are similar to those obtained with the 
cytoplasmic El isozyme using disulfiram as an in- 
hibitor [7]. 
Although diethyldithiocarbamic acid 2-mer- 
captoethanol mixed disulfide is a potent inhibitor 
of the mitochondrial isozyme, 2-mercaptoethanol 
is not known to occur in living organisms. In 
search of physiologically occurring compounds 
which would react with disulfiram or diethyldithio- 
carbamic acid to yield mixed disulfides (in addition 
to those listed in section l), we came upon the 
recently described transamination pathway for the 
degradation of methionine [ 161. This pathway pro- 
duces a mercaptan intermediate methanethiol 
[ 16-181. Synthesis and purification of the diethyl- 
dithiocarbamic acid methanethiol mixed disulfide 
(fig.1) was performed (table 1) and its inhibitory 
properties toward the mitochondrial isozyme ex- 
amined. Diethyldithiocarbamic acid methanethiol 
mixed disulfide inhibited the mitochondrial iso- 
zyme rapidly (table 1) and at stoichiometric con- 
centrations (fig.2). The inhibition was reversible 
on addition of 10 mM 2-mercaptoethanol. Dime- 
thy1 disulfide (35 mM) did not inhibit the enzyme. 
The inhibition with diethyldithiocarbamic acid 
EOLWALENTSITETRAMER 
Fig.2. Inactivation of human mitochondrial aldehyde 
dehydrogenase E2 by diethyldithiocarbamic acid me- 
thanethiol mixed disulfide. Inactivation was done as 
described in text. 
79 
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methanethiol mixed disulfide occurred in a way 
analogous to that observed with the 2-mercapto- 
ethanol mixed disulfide and to the inhibition of the 
cytoplasmic isozyme by disulfiram [7]. 
Further investigations were designed to deter- 
mine why compounds such as the diethyldithiocar- 
bamic acid methanethiol mixed disulfide and 
disulfiram, although structurally similar (fig. l), 
have different inhibitory properties toward the 
mitochondrial E2 isozyme but are equally effective 
with the cytoplasmic El isozyme. Since both com- 
pounds are neutral, charge was not a considera- 
tion; however, size differences indicated the 
possibility that steric hindrance may play a role in 
limiting the binding to smaller molecules. This was 
investigated by measuring the rate constants for 
the inhibition of the mitochondrial E2 isozyme ac- 
tivity by mixed disulfide compounds of increasing 
chain length (table 1). It can be seen that diethyldi- 
thiocarbamic acid methanethiol mixed disulfide 
(the smallest molecule in this series) inhibits the 
mitochondrial isozyme most effectively; as the 
chain length increases, the rate of inhibition 
decreases until a degree of inhibition similar to that 
with disulfiram is obtained. It appears that a 
similar disulfiram recognition site exists in both 
cytoplasmic and mitochondrial isozymes but due 
to a more compact three-dimensional structure 
disulfiram is precluded from binding in the mito- 
chondrial isozyme in the way necessary to effi- 
ciently inhibit activity. 
It is important to note that methanethiol is a 
normal metabolite [19] which can be detected at 
low levels in the breath of normal individuals [20] 
but occurs at elevated levels in individuals with 
liver damage [16,20], including alcoholics. This 
elevation appears to result from a decrease in the 
transsulfuration pathway relative to the trans- 
amination pathway of methionine metabolism 
[16,21]. It has also been reported that individuals 
with alcoholic liver damage [22] exhibit disulfiram- 
ethanol reaction for much longer periods following 
discontinuation of disulfiram treatment han nor- 
mal individuals. Although no explanation for this 
has been provided [22] it appears likely that the 
persistence of disulfiram-ethanol reaction in 
alcoholics with liver damage may be proportional 
to the production of methanethiol. In this regard, 
it is especially interesting that the transaminative 
pathway of methionine degradation is localized in 
80 
the mitochondria [23], thus facilitating the toxic 
effects of methanethiol with respect to mitochon- 
drial aldehyde dehydrogenase. 
We have demonstrated that the low-K,,, mito- 
chondrial isozyme of human aldehyde dehydro- 
genase can be efficiently inhibited by a potential 
physiological metabolite of disulfiram: diethyldi- 
thiocarbamic acid methanethiol mixed disulfide. 
The fact that the approach of disulfiram to the 
essential sulfhydryl group on the mitochondrial 
isozyme is sterically hindered explains why disul- 
firam is not an effective inhibitor of the mitochon- 
drial isozyme in vitro despite its overall inhibitory 
effects on total low-K,,, aldehyde dehydrogenase 
activity in vivo. Since methanethiol occurs natural- 
ly, is elevated in alcoholic liver damage [16] and 
the pathway of its formation is localized in mito- 
chondria [23], it is postulated that diethyldithio- 
carbamic acid methanethiol mixed disulfide is the 
in vivo metabolite of disulfiram which inhibits 
mitochondrial aldehyde dehydrogenase. 
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